CINECA IRIS Institutional Research Information System

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

DI MAIO, Massimo;Leighl NB;Gallo C;Feld R;Ciardiello F;Butts C;Maione P;Gebbia V;Morgillo F;Wierzbicki R;Favaretto A;Alam Y;Cinieri S;Siena S;Bianco R;Riccardi F;Spatafora M;Ravaioli A;Felletti R;Fregoni V;Genestreti G;Rossi A;Mancuso G;Fasano M;Morabito A;Tsao MS;Signoriello S;Perrone F;Gridelli C;TORCH Investigators

2012-01-01